The Biden administration revealed plans to seek lower prices for widely used diabetes, cancer, and arthritis drugs as well as clot preventers amid continuing industry opposition to negotiations.
and has kept tabs on the pharmacy programs since its launch in 2006.
Separately, the influential Chamber of Commerce is making a strong push to at least delay the implementation of the Medicare Part D drug negotiations.
Democrats were equally firm and vocal in their support of the negotiations. Senate Finance Chairman Ron Wyden issued a statement on Tuesday that said the release of the list of the 10 drugs selected for Medicare drug negotiations is part of a"seismic shift in the relationship between Big Pharma, the federal government, and seniors who are counting on lower prices.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
First drugs picked to be targeted for Medicare price negotiationsPresident Joe Biden's administration released a list of 10 drugs for which the federal government will take a first-ever step: negotiating drug prices directly with the manufacturer.
Weiterlesen »
10 drugs targeted for Medicare price negotiations as Biden pitches cost reductionsPresident Joe Biden is celebrating a new phase of his administration's efforts to lower medical costs
Weiterlesen »
Medicare announces first 10 drugs for price negotiation: Is your prescription on the list?Negotiations for the first group of selected drugs will begin in 2023, with negotiated prices going into effect in 2026.
Weiterlesen »